Accelerator Directory / Institute Of Cancer Research: Royal Cancer Hospital (the)
Business Description
We are world leaders in identifying cancer genes, discovering cancer drugs and developing precision radiotherapy. Together with our hospital partner The Royal Marsden NHS Foundation Trust, we are rated in the top four centres for cancer research and treatment worldwide.
As well as being as world-class research institute, the ICR is a higher education institution and a college of the University of London. We came top in the league table of university research quality compiled from the Research Excellence Framework (REF 2014).
The ICR has charitable status and relies on support from partner organisations, charities, donors and the general public.
The ICR is led by Chief Executive, Professor Paul Workman — an expert in cancer drug discovery.
The majority of ICR employees are directly engaged in research, but there are also important roles in scientific facilities, academic services, IT, fundraising, communication, human resources, and within our Enterprise unit, which negotiates collaborations between ICR scientists and industry.
The Enterprise Unit acts as the technology and knowledge transfer hub for The Institute of Cancer Research, providing the experience and expertise to put in place a wide range of agreements between our scientists and industry.
Although it is not our primary objective, the ICR has been extremely successful in getting a financial return from the commercial exploitation of its research. This income is largely ploughed back into scientific research at the ICR.
We currently have a number of partnering and licensing opportunities in therapeutics, targets, diagnostic biomarkers, devices, and platform or software applications."
Twitter Feed
The ICRICR_London
VIDEO: Our inspirational patient advocates talk about why they've shared their #CancerStories with the ICR. Share… https://t.co/ntyrQ5jGr2
The ICRICR_London
The @RosetreesT funds outstanding research projects and have made significant awards towards our PhD studentships &… https://t.co/po6sRCXrWS
The ICRICR_London
Find out about the many ways you can support our cancer research and help us make the discoveries to defeat cancer… https://t.co/pmNX6tYyJk
The ICRICR_London
#ICRprofile Dr Yinyin Yuan's team works to reconstruct 2D or 3D tumour models from images of tumour sections… https://t.co/xcDe7k9fef
The ICRICR_London
RT @TargetingCancer: ICYMI: Terrific article from @ICR_London on how organ sparing #radiationtherapy could help reduce side effects for pat…
The ICRICR_London
A popular Science Talk blog post by @henryfrench_ICR: Seven ways we are outsmarting cancer by overcoming drug resis… https://t.co/AH3ygkAF18
The ICRICR_London
In a new blog post, @henryfrench_ICR introduces the latest developments at The #LondonCancerHub, a major regenerati… https://t.co/3Th340D9N3
The ICRICR_London
Did you know that we've collaborated with >25 industrial partners, including @AstraZeneca, @illumina, and @philips?… https://t.co/3gPjeiEgKg
The ICRICR_London
VIDEO: Prof Raj Chopra explains Pillar 2 ('Innovative approaches') of our joint research strategy with… https://t.co/bPboVmPR0F
